Crossmark Global Holdings Inc. Buys New Position in Cardinal Health, Inc. (NYSE:CAH)

Crossmark Global Holdings Inc. bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 44,858 shares of the company’s stock, valued at approximately $3,002,000.

Several other hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. boosted its holdings in Cardinal Health by 72.1% in the 2nd quarter. Franklin Resources Inc. now owns 6,283,529 shares of the company’s stock valued at $489,613,000 after purchasing an additional 2,632,836 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Cardinal Health by 71.4% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,557,123 shares of the company’s stock worth $277,191,000 after acquiring an additional 1,482,285 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Cardinal Health by 6.5% in the 2nd quarter. BlackRock Inc. now owns 22,843,418 shares of the company’s stock worth $1,779,958,000 after acquiring an additional 1,398,496 shares during the last quarter. HealthCor Management L.P. acquired a new position in shares of Cardinal Health in the 2nd quarter worth approximately $84,496,000. Finally, Teachers Advisors LLC lifted its holdings in shares of Cardinal Health by 141.3% in the 2nd quarter. Teachers Advisors LLC now owns 1,637,285 shares of the company’s stock worth $127,577,000 after acquiring an additional 958,792 shares during the last quarter. 88.64% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Crossmark Global Holdings Inc. Buys New Position in Cardinal Health, Inc. (NYSE:CAH)” was reported by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.truebluetribune.com/2017/11/14/crossmark-global-holdings-inc-purchases-shares-of-44858-cardinal-health-inc-cah.html.

Several equities research analysts recently weighed in on the stock. Royal Bank Of Canada assumed coverage on shares of Cardinal Health in a research note on Tuesday, September 19th. They set a “sector perform” rating and a $72.00 target price on the stock. Jefferies Group LLC reaffirmed a “hold” rating and set a $77.00 target price on shares of Cardinal Health in a research note on Thursday, July 27th. UBS AG reissued a “neutral” rating and issued a $76.00 price objective (down from $79.00) on shares of Cardinal Health in a research report on Wednesday, August 9th. Credit Suisse Group dropped their price objective on shares of Cardinal Health from $87.00 to $81.00 and set an “outperform” rating on the stock in a research report on Thursday, August 3rd. Finally, BidaskClub downgraded shares of Cardinal Health from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company’s stock. Cardinal Health presently has a consensus rating of “Hold” and an average target price of $74.81.

Shares of Cardinal Health, Inc. (NYSE:CAH) opened at $57.05 on Tuesday. The company has a market cap of $18,420.04, a PE ratio of 11.11, a PEG ratio of 1.69 and a beta of 0.88. Cardinal Health, Inc. has a twelve month low of $57.54 and a twelve month high of $84.88. The company has a current ratio of 1.06, a quick ratio of 0.52 and a debt-to-equity ratio of 1.35.

Cardinal Health (NYSE:CAH) last released its earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.09. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The business had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $33.48 billion. During the same period last year, the company earned $1.24 earnings per share. The company’s quarterly revenue was up 1.9% on a year-over-year basis. research analysts predict that Cardinal Health, Inc. will post 4.97 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.4624 per share. The ex-dividend date is Friday, December 29th. This represents a $1.85 dividend on an annualized basis and a yield of 3.24%. Cardinal Health’s dividend payout ratio (DPR) is 53.78%.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply